| Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients H Back, JB Lee, N Han, S Goo, E Jung, J Kim, B Song, SH An, JT Kim, ... Pharmaceutics 11 (6), 259, 2019 | 20 | 2019 |
| Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC‐MS/MS J Chae, H Baek, SK Kim, H Kang, K Kwon Biomedical Chromatography 27 (8), 953-955, 2013 | 16 | 2013 |
| Beyond the Michaelis‐Menten: Accurate Prediction of In Vivo Hepatic Clearance for Drugs With Low KM H Back, H Yun, SK Kim, JK Kim Clinical and translational science 13 (6), 1199-1207, 2020 | 12 | 2020 |
| A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption H Back, B Song, S Pradhan, J Chae, N Han, W Kang, MJ Chang, J Zheng, ... BMC Pharmacology and Toxicology 19, 1-10, 2018 | 12 | 2018 |
| BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing … J Chae, YL Teo, HK Ho, J Lee, H Back, H Yun, MO Karlsson, K Kwon, ... Cancer chemotherapy and pharmacology 78, 623-632, 2016 | 10 | 2016 |
| Prediction of Methionine and Homocysteine levels in Zucker diabetic fatty (ZDF) rats as a T2DM animal model after consumption of a Methionine-rich diet N Han, J Chae, J Jeon, J Lee, H Back, B Song, K Kwon, SK Kim, H Yun Nutrition & metabolism 15, 1-8, 2018 | 9 | 2018 |
| A Reactive Oxygen Species-Scavenging ‘Stealth’Polymer, Poly (thioglycidyl glycerol), Outperforms Poly (ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances … R d’Arcy, F El Mohtadi, N Francini, CR DeJulius, H Back, A Gennari, ... Journal of the American Chemical Society 144 (46), 21304-21317, 2022 | 8 | 2022 |
| Predicting Intestinal and Hepatic First-Pass Metabolism of Orally Administered Testosterone Undecanoate A Zgair, Y Dawood, SM Ibrahem, H Back, L Kagan, P Gershkovich, JB Lee Applied Sciences 10 (20), 7283, 2020 | 7 | 2020 |
| Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from … S Pradhan, B Song, J Lee, J Chae, KI Kim, H Back, N Han, K Kwon, H Yun BMC Medical Research Methodology 17, 1-9, 2017 | 7 | 2017 |
| A novel HPLC–MS/MS method for the simultaneous determination of astemizole and its major metabolite in dog or monkey plasma and application to pharmacokinetics H Back, JH Lee, J Chae, B Song, JW Seo, H Yun, K Kwon Journal of pharmaceutical and biomedical analysis 114, 121-126, 2015 | 7 | 2015 |
| Application of an Inter-Species Extrapolation Method for the Prediction of Drug Interactions between Propolis and Duloxetine in Humans TL Ngo, CH Lee, N Han, HM Back, SJ Rhee, K Noh, HY Yun, W Kang, ... International Journal of Molecular Sciences 21 (5), 1862, 2020 | 6 | 2020 |
| Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans MD Chiang, K Frey, C Lee, ED Kharasch, D Tallchief, C Sawyer, J Blood, ... British Journal of Clinical Pharmacology 87 (2), 516-526, 2021 | 5 | 2021 |
| Clinical Evaluation of Acetaminophen–Galgeuntang Interaction Based on Population Approaches QT Tran, SJ Park, H Back, LT Ngo, DT Cao, HV Nguyen, S Jung, J Chae, ... Pharmaceutics 12 (12), 1182, 2020 | 5 | 2020 |
| Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor‐Mediated Recycling of HL2351, a Novel Hybrid Fc‐Fused Interleukin‐1 Receptor Antagonist, to Optimize … L Ngo, J Oh, A Kim, H Back, W Kang, J Chae, H Yun, H Lee CPT: pharmacometrics & systems pharmacology 9 (10), 584-595, 2020 | 5 | 2020 |
| Evaluation and enhancement of standard equations for renal function estimation in individuals with components of metabolic disease L Brunetti, H Back, S Yu, U Jalil, L Kagan BMC nephrology 22, 1-10, 2021 | 4 | 2021 |
| Pharmacokinetics of Shikimic Acid Following Intragastric and Intravenous Administrations in Rats K Noh, HM Back, BS Shin, W Kang Pharmaceutics 12 (9), 824, 2020 | 4 | 2020 |
| Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study I Zentner, H Back, L Kagan, S Subbian, J Nagajyothi, S Srivastava, ... Frontiers in pharmacology 11, 1103, 2020 | 4 | 2020 |
| Dose Optimization Based on Population Pharmacokinetic Modeling of High-Dose Cyclosporine, a P-glycoprotein Inhibitor, in Combination with Systemic Chemotherapy in Pediatric … YS Ree, H Back, H Yun, JH Ahn, ES Son, JW Han, CJ Lyu, SJ Rhie Journal of Ocular Pharmacology and Therapeutics 34 (9), 647-655, 2018 | 4 | 2018 |
| Determination of matrine in rat plasma after oral administration of novel korean herbal medicine KIOM-MA128 and application of PK H Back, B Song, J Chae, H Yun, JY Ma, K Kwon Journal of analytical methods in chemistry 2015, 2015 | 4 | 2015 |
| Development of a population pharmacokinetic model to describe olmesartan medoxomil/hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects. J Chae, I Baek, J Seo, S Jung, H Back, B Song, B Lee, H Yun, W Kang, ... International journal of clinical pharmacology and therapeutics 52 (8), 676-683, 2014 | 4 | 2014 |
